Rapport Therapeutics Inc (RAPP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RAPP | AZN | AMGN | GILD | BMY |
| Company | Rapport Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 33.56 | 204.75 | 345.45 | 139.24 | 59.12 |
| High | 34.24 | 204.75 | 348.17 | 140.71 | 59.63 |
| Low | 33.31 | 203.30 | 343.37 | 138.85 | 58.77 |
| Latest | 34.11 | 203.98 | 343.79 | 139.70 | 59.03 |
| Change | +0.53 | +0.49 | -4.15 | -0.01 | -0.57 |
| % Change | +1.58% | +0.24% | -1.19% | -0.01% | -0.96% |
| Volume | 53,947 | 290,076 | 598,125 | 585,063 | 1,269,156 |
| 20-Day Average Volume | 349,754 | 1,778,147 | 2,577,143 | 5,929,786 | 13,255,068 |
| Previous Close | 33.58 | 203.49 | 347.94 | 139.71 | 59.60 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 29.18 | 191.89 | 357.06 | 141.04 | 59.26 |
| 20-Day Raw Stochastic | 95.69% | 95.66% | 2.69% | 37.54% | 45.37% |
| 20-Day Relative Strength | 64.94 | 60.32 | 41.22 | 47.84 | 50.04 |
| Weighted Alpha | +114.01 | +52.82 | +20.21 | +34.12 | +22.98 |
| Today's Opinion | 100% Buy | 88% Buy | 24% Buy | 40% Buy | 72% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 40% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 88% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +21.71% since 03/27/26 | +8.15% since 03/27/26 | -1.26% since 03/27/26 | +4.06% since 03/27/26 | +0.91% since 03/27/26 |
| Low | 27.02 on 03/30/26 | 192.61 on 03/30/26 | 343.37 on 04/06/26 | 133.89 on 03/30/26 | 58.83 on 04/06/26 |
| High | 34.24 on 04/06/26 | 204.75 on 04/06/26 | 357.00 on 04/01/26 | 141.49 on 04/01/26 | 62.22 on 04/01/26 |
| 1-Month | |||||
| %Chg | +12.05% since 03/06/26 | +4.92% since 03/06/26 | -6.81% since 03/06/26 | -2.94% since 03/06/26 | -2.02% since 03/06/26 |
| Low | 26.01 on 03/19/26 | 182.39 on 03/24/26 | 343.37 on 04/06/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 34.24 on 04/06/26 | 204.75 on 04/06/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +22.51% since 01/06/26 | +7.30% since 01/06/26 | +4.30% since 01/06/26 | +15.12% since 01/06/26 | +8.54% since 01/06/26 |
| Low | 25.21 on 02/05/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 53.54 on 01/21/26 |
| High | 34.24 on 04/06/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +22.15% since 10/06/25 | +19.18% since 10/06/25 | +17.08% since 10/06/25 | +23.00% since 10/06/25 | +30.86% since 10/06/25 |
| Low | 23.75 on 11/17/25 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 112.82 on 10/07/25 | 42.52 on 10/29/25 |
| High | 34.24 on 04/06/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,605,124 | 315,594,272 | 187,563,328 | 173,411,136 | 121,687,400 |
| Shares Outstanding, K | 47,800 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -111,480,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -33,760,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.09 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.72 on 03/10/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/14/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.91 | 16.17 | 17.21 | 10.04 |